Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Anaemia is the most frequent, though often neglected, comorbidity of inflammatory bowel disease (IBD). Here we want to briefly present (1) the burden of anaemia in IBD, (2) its pathophysiology, which mostly arises from bleeding-associated iron deficiency, followed by (3) diagnostic evaluation of anaemia, (4) a balanced overview of the different modes of iron replacement therapy, (5) evidence for their therapeutic efficacy and subsequently, (6) an updated recommendation for the practical management of anaemia in IBD. Following the introduction of various intravenous iron preparations over the last decade, questions persist about when to use these preparations as opposed to traditional and other novel oral iron therapeutic agents. At present, oral iron therapy is generally preferred for patients with quiescent IBD and mild iron-deficiency anaemia. However, in patients with flaring IBD that hampers intestinal iron absorption and in those with inadequate responses to or side effects with oral preparations, intravenous iron supplementation is the therapy of choice, although information on the efficacy of intravenous iron in patients with active IBD and anaemia is scare. Importantly, anaemia in IBD is often multifactorial and a careful diagnostic workup is mandatory for optimized treatment. Nevertheless, limited information is available on optimal therapeutic start and end points for treatment of anaemia. Of note, neither oral nor intravenous therapies seem to exacerbate the clinical course of IBD. However, additional prospective studies are still warranted to determine the optimal therapy in complex conditions such as IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · cited 2×
“Thus approximately 1–2 mg originates from dietary intake and the remainder is acquired by recycling of iron from senescent erythrocytes by macrophages [41,43].”
BackgroundFerric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789 · cited 1×
“This is of interest because the composition of the microbiome is regarded as an important factor in the pathogenesis of IBD [120].”
BackgroundCamaschella, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1401038 · Cited by 1,678
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282
Haas, J. D., & Brownlie, T. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.676s · Cited by 1,186
Identification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127 · cited 1×
“These include erythroferrone produced by erythroblasts in response to erythropoeitic stress [58], as well as other mechanisms, including growth differentiation factor 15 (GDF-15), which is seen mainly in patients with hemoglobinopathies.”
BackgroundGanz, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2013 · Cited by 1,122
Sazawal, S., Black, R. E., Ramsan, M., Chwaya, H. M., Stoltzfus, R. J., Dutta, A., Dhingra, U., Kabole, I., Deb, S., Othman, M. K., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67962-2 · Cited by 981 · cited 1×
“Thus, dietary iron fortification strategies were associated with an increased risk of infections such as malaria, bacterial meningitis, bacterial pneumonia and viral diarrhoea along with a rise in infection-related mortality [189,190].”
BackgroundSerum Transferrin Receptor and Its Ratio to Serum Ferritin in the Diagnosis of Iron Deficiency
Punnonen, K., Irjala, K., & Rajamäki, A. (1997) · Blood · doi:10.1182/blood.v89.3.1052 · Cited by 859 · cited 1×
“, the sTfR-F index) has been recommended [78].”
BackgroundHigh levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639
Mechanisms of mammalian iron homeostasis
Pantopoulos, K., Porwal, S. K., Tartakoff, A., & Devireddy, L. (2012) · Biochemistry · doi:10.1021/bi300752r · Cited by 598 · cited 1×
“Thus approximately 1–2 mg originates from dietary intake and the remainder is acquired by recycling of iron from senescent erythrocytes by macrophages [41,43].”
BackgroundLabile plasma iron in iron overload: redox activity and susceptibility to chelation
Esposito, B. P., Breuer, W., Sirankapracha, P., Pootrakul, P., Hershko, C., & Cabantchik, Z. I. (2003) · Blood · doi:10.1182/blood-2003-03-0807 · Cited by 475
Hepcidin and disorders of iron metabolism
Ganz, T., & Nemeth, E. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-050109-142444 · Cited by 466 · cited 1×
“In contrast, during states of iron deficiency, hypoxia and anaemia, the synthesis of hepcidin is blocked in order to increase serum iron levels [29,49,51].”
BackgroundDiagnosis and Management of Iron-Deficiency Anaemia
COOK, J. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.022 · Cited by 452 · cited 2×
“Generally, nausea and abdominal discomfort occur within 1–2 h of drug intake and appear to be dose related, whereas other gastrointestinal side effects such as diarrhoea and constipation are idiosyncratic [71,111].”
BackgroundStoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., Moretti, D., & Zimmermann, M. B. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30182-5 · Cited by 435 · cited 1×
“This observation, combined with a very recent study in women with depleted iron stores demonstrating that alternate-day administration of oral iron supplementation resulted in higher fractional as well as total iron absorption compared with daily administration [113], may alter the current practice of oral iron admini…”
ResultCytokine-mediated regulation of iron transport in human monocytic cells
Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood · doi:10.1182/blood-2002-08-2459 · Cited by 420
Hepcidin in the diagnosis of iron disorders
Girelli, D., Nemeth, E., & Swinkels, D. W. (2016) · Blood · doi:10.1182/blood-2015-12-639112 · Cited by 417 · cited 1×
“Recently, commercially available tests have been introduced into clinical practice [83] but the usefulness of hepcidin determination to correctly indicate iron deficiency in patients with inflammation needs to be tested prospectively in future studies.”
BackgroundDetection, evaluation, and management of iron-restricted erythropoiesis
Goodnough, L. T., Nemeth, E., & Ganz, T. (2010) · Blood · doi:10.1182/blood-2010-05-286260 · Cited by 410 · cited 1×
“Accordingly, prospective evaluations of this parameter, as well as of the reticulocyte haemoglobin content in clinical situations, including patients with anaemia and inflammatory disorders, are scarce [68,81].”
BackgroundKoskenkorva-Frank, T. S., Weiss, G., Koppenol, W. H., & Burckhardt, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.001 · Cited by 406
Suppression of iron-regulatory hepcidin by vitamin D
Bacchetta, J., Zaritsky, J. J., Sea, J. L., Chun, R. F., Lisse, T. S., Zavala, K., Nayak, A., Wesseling-Perry, K., Westerman, M., Hollis, B. W., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013040355 · Cited by 350
Soofi, S., Cousens, S., Iqbal, S. P., Akhund, T., Khan, J., Ahmed, I., Zaidi, A. K., & Bhutta, Z. A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60437-7 · Cited by 330 · cited 1×
“Thus, dietary iron fortification strategies were associated with an increased risk of infections such as malaria, bacterial meningitis, bacterial pneumonia and viral diarrhoea along with a rise in infection-related mortality [189,190].”
BackgroundTolerability of different oral iron supplements: a systematic review
Cancelo-Hidalgo, M. J., Castelo-Branco, C., Palacios, S., Haya-Palazuelos, J., Ciria-Recasens, M., Manasanch, J., & Pérez-Edo, L. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761599 · Cited by 320 · cited 2×
“Oral iron supplements are available as divalent Fe2+ (ferrous) or trivalent Fe3+ (ferric) salts coupled with sugar complexes or protein succinylate [95,96].”
BackgroundDepletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis
Werner, T., Wagner, S. J., Martínez, I., Walter, J., Chang, J.-S., Clavel, T., Kisling, S., Schuemann, K., & Haller, D. (2011) · Gut · doi:10.1136/gut.2010.216929 · Cited by 299 · cited 1×
“Based on these findings, iron ingestion may potentially influence the disease course in patients with IBD [118,121].”
BackgroundOxidative Stress and the Homeodynamics of Iron Metabolism
Bresgen, N., & Eckl, P. (2015) · Biomolecules · doi:10.3390/biom5020808 · Cited by 247
Fuqua, B. K., Vulpe, C. D., & Anderson, G. J. (2012) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2012.03.015 · Cited by 241
Common Misconceptions in the Diagnosis and Management of Anemia in Inflammatory Bowel Disease
Gisbert, J. P., & Gomollón, F. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01846.x · Cited by 230 · cited 2×
“Hence iron deficiency deserves attention in IBD, where the mean prevalence is shown to be 20% among outpatients [16] and 68% among hospitalized patients [17], exceeding by far the frequencies of other extraintestinal manifestations (e.”
BackgroundSummary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)
Drüeke, T. B., & Parfrey, P. S. (2012) · Kidney International · doi:10.1038/ki.2012.270 · Cited by 229
Santiago, P. (2012) · The Scientific World Journal · doi:10.1100/2012/846824 · Cited by 210
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
Theurl, I., Schroll, A., Sonnweber, T., Nairz, M., Theurl, M., Willenbacher, W., Eller, K., Wolf, D., Seifert, M., Sun, C. C., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345066 · Cited by 189
Theurl, I., Mattle, V., Seifert, M., Mariani, M., Marth, C., & Weiss, G. (2006) · Blood · doi:10.1182/blood-2005-08-3364 · Cited by 188 · cited 2×
“As a consequence of chronic inflammation, patients with active IBD may show reduced levels of transferrin, which is contrary to the definition of patients with iron deficiency [67].”
BackgroundResultBregman, D. B., Morris, D., Koch, T. A., He, A., & Goodnough, L. T. (2013) · American Journal of Hematology · doi:10.1002/ajh.23354 · Cited by 187 · cited 1×
“Thus, high hepcidin concentrations may predict nonresponsiveness to oral iron therapy [52].”
BackgroundThe role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes
Zughaier, S. M., Alvarez, J. A., Sloan, J. H., Konrad, R. J., & Tangpricha, V. (2014) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.01.003 · Cited by 174
Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children
Prentice, A. M., Doherty, C. P., Abrams, S. A., Cox, S. E., Atkinson, S. H., Verhoef, H., Armitage, A. E., & Drakesmith, H. (2012) · Blood · doi:10.1182/blood-2011-11-391219 · Cited by 167
Anaemia in inflammatory rheumatic diseases
Weiss, G., & Schett, G. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.183 · Cited by 146 · cited 3×
“The diagnosis of iron deficiency and anaemia is based on measurements of the blood haemoglobin concentration but some additional basic analyses are required for a diagnostic workup and for tailoring optimal therapy in patients with IBD [29,38,65].”
BackgroundHypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB
Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., Haschka, D., Mitterstiller, A.-M., Kleinsasser, A., Burtscher, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305317 · Cited by 145
Favrat, B., Balck, K., Breymann, C., Hedenus, M., Keller, T., Mezzacasa, A., & Gasche, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094217 · Cited by 130 · cited 1×
“Thus, none of these observational, single centre studies included a placebo control given the high incidence of placebo mediated benefits on quality of life in such patient cohorts [174,177].”
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
Sebastiani, G., Wilkinson, N., & Pantopoulos, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00160 · Cited by 127
Anemia of chronic disease: pathophysiology and laboratory diagnosis.
THOMAS, C., & THOMAS, L. (2005) · Laboratory Hematology · doi:10.1532/lh96.04049 · Cited by 124
Role of divalent metals in infectious disease susceptibility and outcome
Weiss, G., & Carver, P. L. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.018 · Cited by 123
Anemia of chronic disorders: new diagnostic tools and new treatment strategies
Weiss, G. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.07.004 · Cited by 116
‘Ride on the ferrous wheel’ – The cycle of iron in macrophages in health and disease
Nairz, M., Schroll, A., Demetz, E., Tancevski, I., Theurl, I., & Weiss, G. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.09.010 · Cited by 89
Diagnosis of iron-deficient states
Archer, N. M., & Brugnara, C. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1038744 · Cited by 82
Dietary iron loading negatively affects liver mitochondrial function
Volani, C., Doerrier, C., Demetz, E., Haschka, D., Paglia, G., Lavdas, A. A., Gnaiger, E., & Weiss, G. (2017) · Metallomics · doi:10.1039/c7mt00177k · Cited by 59 · cited 1×
“as impairment of mitochondrial function with subsequent fatigue [178].”
BackgroundHigh-Molecular Weight Iron Dextran: A Wolf in Sheep's Clothing?
Rodgers, G. M., Auerbach, M., Cella, D., Chertow, G. M., Coyne, D. W., Glaspy, J. A., & Henry, D. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030255 · Cited by 56
Sonnweber, T., Theurl, I., Seifert, M., Schroll, A., Eder, S., Mayer, G., & Weiss, G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq483 · Cited by 55
Hematologic parameters predicting a response to oral iron therapy in chronic inflammation
van Santen, S., de Mast, Q., Oosting, J. D., van Ede, A., Swinkels, D. W., & van der Ven, A. J. A. M. (2014) · Haematologica · doi:10.3324/haematol.2014.106799 · Cited by 44 · cited 3×
“The assessment should be guided by predictive serum parameters such as hepcidin, soluble transferrin receptor and others including red cell indices but no gold standard is available at present [76,84].”
Background
Cited by
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
Diet and inflammatory bowel disease: the Asian Working Group guidelines
Sood, A., Ahuja, V., Kedia, S., Midha, V., Mahajan, R., Mehta, V., Sudhakar, R., Singh, A., Kumar, A., Puri, A. S., et al. (2019) · Indian Journal of Gastroenterology · doi:10.1007/s12664-019-00976-1 · Cited by 54
Iron at the host-microbe interface
Gerner, R. R., Nuccio, S.-P., & Raffatellu, M. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100895 · Cited by 45
Metadata
- Authors
- Nielsen, O., Soendergaard, C., Vikner, M., & Weiss, G.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-01-13
- Volume
- 10
- Issue
- 1
- Pages
- 82
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2783641539
- Cited by
- 76
- References
- 52
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.